secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inspire Medical Systems, Inc. (INSP)
CIK:        0001609550
Form:       8-K
Filed at:   2026-08-03T20:03:40+00:00
Accession:  0001609550-26-000045
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inspire Medical Q2 revenue down 7.6% to $200.6M; raises FY2026 guidance; announces Project Horizon restructuring
--------------------------------------------------------------------------------

- Q2 revenue $200.6M (-7.6% YoY); diluted EPS $0.01, adjusted diluted EPS $0.14.
- Gross margin 85.5% (+150 bps); operating cash flow $23.2M vs $2.7M prior year.
- Raised FY2026 revenue guidance to $835M-$875M; adjusted diluted EPS guidance $1.05-$1.45.
- Announced Project Horizon restructuring to generate $30M annualized growth investment capacity; expects $20M-$25M pre-tax charges.
- Cash and investments $415.2M as of June 30, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609550/000160955026000045/0001609550-26-000045-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609550/000160955026000045/insp-20260803.htm
  HTML page:      https://secwatch.observer/filing/0001609550-26-000045

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer